VIP (Vasoactive Intestinal Peptide): Research Overview

VIP, or vasoactive intestinal peptide, is a 28-amino-acid neuropeptide in the glucagon/secretin superfamily. Research sources describe it as both a neuromodulator and a neurotransmitter, with actions in the gut, lungs, heart, brain, and immune system. It signals through the VPAC1 and VPAC2 receptors, and its blood half-life is short, about two minutes.

• VIP is a small signaling peptide with broad effects on smooth muscle, blood vessels, secretion, and neural activity.
• Research links VIP to circadian timing, sleep-wake regulation, and inhibitory interneuron circuits in the brain.
• It also has reported anti-inflammatory, bronchodilatory, and immunomodulatory roles.
• Most of the most specific claims come from older foundational studies and review sources, not from large modern clinical trials.

What VIP Is

VIP stands for vasoactive intestinal peptide. It is also called vasoactive intestinal polypeptide in some sources. It belongs to the same broader family as other secretin-like peptides. One source describes it as being produced in many vertebrate tissues, including the gut, pancreas, neocortex, and hypothalamic suprachiasmatic nuclei.

The name reflects one of its first known actions: strong effects on blood vessels and intestinal tone. Research summaries describe VIP as a peptide that can relax smooth muscle, increase blood flow through vasodilation, and affect secretion in the digestive tract. In humans, it is encoded by the VIP gene.

VIP is short-lived. A research summary notes a blood half-life of about two minutes. That matters because short-lived signaling molecules often act more like local messengers than long-range hormones. VIP appears to do both, depending on where it is released and which receptors are present.

Core molecular facts

Several concrete details show up again and again in the research record:

VIP is 28 amino acids long. It works through VPAC1 and VPAC2 receptors. It is found in the nervous system and in peripheral tissues. These facts make it easier to understand why VIP shows up in such different topics, from gut motility to hippocampal learning.

Where VIP Acts

VIP is not limited to one organ system. The research bundle points to several major areas where it matters.

Digestive system

In the digestive tract, VIP is described as a smooth muscle relaxant. It can relax the lower esophageal sphincter, stomach, and gallbladder. It also stimulates water and electrolyte secretion in the intestine and increases pancreatic and biliary secretions. One source also notes inhibition of gastric acid secretion and intestinal absorption, which fits with a role in balancing digestion and fluid movement.

These actions can sound scattered, but they point to one theme: VIP helps regulate the movement of fluid, muscle, and signaling in the gut.

Respiratory system

VIP is also linked to the lungs. One clinic reference describes it as a key endogenous bronchodilator and pulmonary vasodilator. In that context, VIP helps relax airway smooth muscle and support vessel tone in the lung. The same source notes that VIP-deficient states are associated with pulmonary arterial hypertension and airway hyperresponsiveness.

That does not prove VIP is a treatment for those conditions. It does suggest that the peptide is part of the body’s own airway and pulmonary vascular control system.

Cardiovascular system

VIP has cardiovascular effects as well. A research summary says it causes coronary vasodilation and can have positive inotropic and chronotropic effects, meaning it may increase the force and rate of heart contraction. Those actions help explain why older literature often grouped VIP with vasoactive peptides rather than only with brain signaling molecules.

VIP in the Brain

Some of the most interesting modern work on VIP is in neuroscience. The research bundle includes papers that connect VIP to inhibitory circuits, hippocampal learning, and behavior-dependent neural dynamics.

Interneurons and learning

A 2019 Neuron study, cited in the research bundle, reported that vasoactive intestinal polypeptide-expressing interneurons in the hippocampus support goal-oriented spatial learning. That is a specific and useful result. It places VIP not just in broad brain signaling, but in identified inhibitory cells tied to a learning task.

Another 2026 Neuron paper in the bundle used all-optical electrophysiology to study behavior-dependent dynamics of excitation and inhibition in the hippocampus. While the title does not make VIP the central result, it reinforces the larger point that excitation and inhibition in hippocampal circuits remain active research areas where VIP-expressing interneurons are relevant.

Circadian rhythm and sleep

VIP is also connected to circadian timing. One source describes VIP as a chronobiotic peptide, meaning it helps regulate biological rhythms. It says VIP produced by neurons in the suprachiasmatic nucleus is required for normal sleep-wake cycle maintenance and circadian rhythm entrainment.

This fits a wider pattern in the research bundle: VIP is often discussed as a coordinating signal. In the brain, that coordination includes rhythm, state, and inhibitory balance, not just single-cell action.

Neuroprotection and neurobiology

Older review material in the bundle describes VIP as having neuroprotective potential. It also notes that VIP has been discussed as an amnestic neuropeptide in earlier work. Those are not the same thing as proven clinical benefits. They do show that VIP has been studied for its possible effects on memory, injury response, and brain resilience for decades.

More broadly, VIP appears in both central and peripheral nervous systems. That wide distribution helps explain why it continues to attract attention in neuroscience.

VIP, Immunity, and Inflammation

Several sources in the bundle frame VIP as an immunomodulatory peptide. One clinic source says VIP can suppress NF-kB activation and downstream inflammatory signals such as IL-6, TNF-alpha, IL-12, and MMP-9 while promoting IL-10 and TGF-beta1 signaling. It also describes effects on T cells, macrophages, and dendritic cells.

Another older review in the bundle is focused on direct effects of VIP on immune cells. Even from the title alone, it is clear that VIP has long been considered a peptide with real immune activity, not just a neural one.

That said, immune effects do not automatically translate to clinical use. The available research snippets support a biological role, not a finished treatment story. VIP may help shape immune signaling, but the strength, direction, and meaning of those effects can depend on tissue, dose, timing, and disease state.

Inflammation and disease context

One of the search results in the bundle points to inflammatory bowel disease and a possible upregulation of communication between mast cells and VIP in colitis. That supports the idea that VIP is relevant in inflammatory conditions of the gut. It does not, by itself, establish that more VIP is better. In signaling biology, context matters.

VIP is also tied in some sources to pulmonary and airway inflammation. The repeated theme is not that VIP is a simple anti-inflammatory switch, but that it may help shape inflammatory tone across multiple systems.

What the Research Does Not Prove

VIP has a long paper trail, but not all of it is equally strong. The bundle includes older mechanistic studies, review articles, and broader reference pages. Those are useful for understanding biology, but they are not the same as large modern human trials.

So the safest reading is this: VIP is a real endogenous peptide with clear biological actions. It is involved in smooth muscle control, secretion, vasodilation, circadian timing, inhibitory neural circuits, and immune signaling. But that does not mean every proposed use of VIP is proven, and it does not mean the peptide has one single effect across all tissues.

For a science-first audience, that distinction matters. VIP is best understood as a multi-system regulator with context-dependent actions.

How VIP Fits with Other Peptides

VIP is often discussed alongside related neuropeptides. The research bundle explicitly pairs it with PACAP in a review of neuroprotective potential. That makes sense because both peptides sit in overlapping signaling families and have been studied in nervous system biology.

You may also see VIP discussed near other signaling peptides that shape inflammation, circadian rhythm, or neural inhibition. When comparing peptides, the important question is not just what they are named. It is which receptors they activate, where they are produced, and which tissues they influence.

For related reading, see PACAP and PHI.

Research Questions That Still Matter

Even with decades of study, VIP still raises basic questions. Which effects are local and which are systemic? How much of its action comes from neuron-to-neuron signaling versus tissue-level regulation? What determines whether VIP supports calm, secretion, bronchodilation, or immune balance in a given setting?

The current bundle suggests that VIP is important in all of those areas, but it does not resolve them. That is normal for a peptide with broad distribution and short half-life. Fast signaling molecules are often hardest to study because their effects depend on timing and location.

For researchers, that means VIP is still a useful example of how one peptide can sit at the intersection of neurobiology, immunology, and physiology.

FAQ

What is VIP?

VIP is vasoactive intestinal peptide, a 28-amino-acid neuropeptide. Research sources describe it as a neuromodulator and neurotransmitter with effects in the gut, lungs, heart, brain, and immune system.

What receptors does VIP use?

VIP signals through VPAC1 and VPAC2 receptors. Those receptors are found in multiple tissues, which helps explain why VIP has broad effects across body systems.

How long does VIP stay in the blood?

One source in the bundle says VIP has a blood half-life of about two minutes. That is short, so its effects are likely to depend on local release and rapid signaling.

Is VIP only a gut peptide?

No. It was first named for intestinal effects, but research now places it in the brain, lungs, heart, and immune system as well. It is produced in many tissues, not just the intestine.

What does current research suggest about VIP in the brain?

Research in the bundle links VIP-expressing interneurons to goal-oriented spatial learning in the hippocampus and connects VIP to circadian rhythm and sleep-wake regulation through the suprachiasmatic nucleus.

Does VIP have anti-inflammatory effects?

Some sources describe VIP as immunomodulatory and anti-inflammatory, with effects on cytokines and immune cell signaling. That supports a biological role, but it does not prove clinical benefit in any specific disease.